Related Experiment Video
Updated: Feb 9, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Dengue Antiviral Development: A Continuing Journey
Jenny G Low1,2, Rene Gatsinga3, Subhash G Vasudevan3
1Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
Abstract:
Dengue fever is a leading cause of illness and mortality in the tropics and subtropics. There are no therapeutics currently available and a recently approved vaccine is not very efficacious demanding an urgent need to develop an effective antiviral. The path to successful dengue drug development depends on availability of relevant preclinical testing models and better understanding of dengue pathogenesis. In recent years, efforts to develop dengue therapeutics have focused on both repurposing approved drugs as well as discovery of new chemical entities that act via virus or host targeted mechanisms. Here, we discuss the various innovative approaches, their outcome, and the lessons gleaned from the development efforts.
Related Concept Videos
The Antiviral System of Bacteria and Archaea: CRISPR
Continuing Care
Continuity of a Function
Continuity Equation
The mass flow rate is expressed as:
Continuity Equation
Equation of Continuity

